SAN FRANCISCO, April 03, 2018 -- Hagens Berman Sobol Shapiro LLP alerts investors in Henry Schein, Inc. (NASDAQ:HSIC) to the May 7, 2018 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York. If you purchased or otherwise acquired Henry Schein securities between March 7, 2013 and February 12, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/HSIC
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On February 12, 2018, the United States Federal Trade Commission (“FTC”) announced it sued Henry Schein and two other dental supply companies.
The FTC charges the Company: (a) illegally restrained price competition for dental products in the United States; (b) distorted prices and undermined the ability of independent dentists to obtain lower prices and discounts for dental products; (c) deprived independent dentists of the benefits of vigorous price and service competition among full-service, national dental distributors; (d) unreasonably reduced output of dental products to dental buying groups; and (e) eliminated or reduced the competitive bidding process for sales to these buying groups.
This news drove the price of Henry Schein shares down $4.79, or about 6.6%, to close at $67.39 on February 13, 2018.
“Henry Schein investors have suffered enormous losses,” said Hagens Berman partner Reed Kathrein. “We’re focused on Defendants’ statements to investors about the Company’s revenues and purported industry competition.”
Whistleblowers: Persons with non-public information regarding Henry Schein should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



